Relmada Therapeutics, a publicly traded specialty pharmaceutical company, is set to address this considerable unmet need with REL-1017 (dextrometha-done or D-methadone), a noncompetitive N-methyl ...
RELX (formerly Reed Elsevier) is a publisher and information provider with activities in medical, legal and business publishing. Among the services it provides is Lexis-Nexis, the information ...